MAY LEE: Open Payments
NPI 1174237127 · REDWOOD CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 21 payments from 8 companies in 2025. Trend: 2023 $80 · 2024 $625 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Otsuka America Pharmaceutical, Inc. | 3 | $154 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Boston Scientific Corporation | 1 | $36 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $23 |
Products named: FARXIGA, JYNARQUE, Fabhalta, PURIFIED CORTROPHIN GEL, Kerendia, JETSTREAM SC, TARPEYO, IBSRELA.
Industry payments across CA — which companies pay providers there.
